Daily equity-report by epic research 26 april 2013

256 views

Published on

Published in: Economy & Finance, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
256
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Daily equity-report by epic research 26 april 2013

  1. 1. -=6HEADLINES Indian Market Indian equity markets were up 1.36% Nifty up by 79.40 pts and settle at5916.30 Sensex up by 227.49 pts at 19406.85 Bank Nifty up by 183.50 pts at 12726.90 Global Market European markets were up with FTSEup by 7.84 closed at 6439 ,CAC up by9.37 closed at 3852 and DAX up 51.71closed at 7810Dow future was up by 11 closed at14626.00WWW.EPICRESEARCH.CO 09752199966DAILY EQUITYNEWSLETTER26THAPRIL 2013 HEADLINES• Coal price pooling hard to put in practice:ex-CIL CMD• Axis Bank appoints KPMG for moneylaundering inquiry• AirAsia India files application to launchoperations• JSW Steel plans to bid for iron oreblocks in Karnataka
  2. 2.  FII’s and DII’sCATEGORY DATE BUY SELL NETFII 25-Apr-13 6226.62 4776.92 1449.7DII 25-Apr-13 1054.58 2324.01 -1269.43 NIFTY DAILY PIVOTSPIVOT R4 R3 R2 R1 PP S1 S2 S3 S4NIFTY 5982 5929 5876 5856 5823 5803 5770 5717 5664WWW.EPICRESEARCH.CO 09752199966MARKET ANALYSIS: Key benchmark indices gained for fourth straight session of trade as the market sentiment was boostedby data showing that foreign funds remained net buyers of Indian stocks on Tuesday, 23 April 2013.The barometer index, the S&P BSE Sensex settled at almost six week high. The 50-unit CNX Niftysettled at over 6-1/2 week high. The Sensex was up 227.49 points or 1.19%, off 28 points from thedays high and up 214.74 points from the days low. The market breadth, indicating the overall healthof the market, was positive. Indian stocks gained for the fourth straight day today, 25 April 2013. The Sensex has risen 675.69points or 3.61% in four trading days from its close of 18,731.16 on 17 April 2013. The Sensex hasrisen 571.08 points or 3.03% in this month so far (till 25 April 2013). The Sensex has declined 19.86points or 0.1% in calendar 2013 so far (till 25 April 2013). From a 52-week high of 20,203.66 on 29January 2013, the Sensex has declined 796.81 points or 3.94%. From a 52-week low of 15,748.98 on 4June 2012, the Sensex has surged 3,657.87 points or 23.23% Coming back to todays trade, index heavyweight Reliance Industries (RIL) edged higher in choppytrade. Another index heavyweight and cigarette major ITC hit record high in volatile trade. Auto stocksrose as slowing wholesale price inflation has raised rate cut expectations. Aviation stocks were indemand. Jet Airways (India) surged nearly 10% after United Arab Emirates-based Etihad Airways onWednesday, 24 April 2013, agreed to pick up a 24% strategic stake in the Indian carrier at a hugepremium to the ruling market price.STOCKS TO WATCH TCS INFOSYS AXIS BANK SUN PHARMASCRIPS IN BAN PERIOD RENUKA HDIL
  3. 3. WWW.EPICRESEARCH.CO 09752199966.EXPERT OPINIONNIFTY Nifty looks Bearish Strategy: Sell on rise Support: 5870 Resistance: 5960BANK NIFTY Bank Nifty looks Bearish Strategy: Sell on rise Support: 12660 Resistance: 12800460 .0 GAINERS AND LOOSERSPREVIOUS PERFORMANCETYPE SCRIP B/S RESULTCASH CAIRN INDIA SNOTEXECUTEDCASHALLAHBADBANKB TGT HITFUTURE AMBUJA B TGT HITFUTURE APOLLO TYRE B SL TRIGERREDDAILY NIFTY GAINERSSCRIPS RATE VOL.(000)PR.CLOSENETCHANGE%CHANGEDrReddys1992.50 1084.75 1901.50 91.00 4.79GAILIndia344.40 1461.36 330.05 14.35 4.35TataMotors293.30 9750.91 281.50 11.80 4.19NTPC 155.25 18633.14 149.05 6.20 4.16AxisBank1503.40 3878.35 1444.80 58.60 4.06DAILY NIFTY LOOSERSSCRIPS RATE VOL.(000)PR.CLOSENETCHANGE%CHANGETCS 1402.30 3964.60 1430.55 -28.25 -1.97DLF 242.45 6308.81 246.90 -4.45 -1.80HCL Tech. 719.05 1995.56 732.15 -13.10 -1.79Infosys 2227.70 1720.29 2262.25 -34.55 -1.53JPAssociate77.45 24855.75 78.40 -0.95 -1.21
  4. 4. 6.MARKET CALLSCASHSCRIPS ACTION LEVEL 1STTARGET 2NDTARGET STOP LOSSAUROBINDOPHARMABUY 192.00 193.00 194.00 191.00IDFC BUY 159.20 160.20 161.20 158.20FUTURESCRIPS ACTION LEVEL 1STTARGET 2NDTARGET STOP LOSSHEXAWARE SELL 84.20 83.20 82.20 85.20WIPRO SELL 334.50 332.50 330.50 336.50DisclaimerThe information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept anyresponsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up onsources that we consider reliable.This material is for personal information and based upon it & takes no responsibilityThe information given herein should be treated as only factor, while making investment decision. The report does not provide individuallytailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, andencourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based onthe information given in this report, which is in violation of rules and regulations of NSE and BSE.The share price projections shown are not necessarily indicative of future price performance. The information herein, together with allestimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocksrecommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any viewsexpressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading ofthe information is the acceptance of this disclaimer.All Rights Reserved. Investment in equity & bullion market has its own risks.We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for anyfinancial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer tobuy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our callsor SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then SeriousLegal Actions can be taken.

×